Evidence map›Paper›PMID 30457424›Full record

ArticleHuman vaccines & immunotherapeutics2019

Commentary: resolving pertussis resurgence and vaccine immunity using mathematical transmission models.

M Domenech de Cellès, A A King, P Rohani

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

M Domenech de Cellèsa Biostatistics, Biomathematics, Pharmacoepidemiology, and Infectious Diseases (B2PHI) Unit , Institut Pasteur, Inserm U1181, University of Versailles St-Quentin-en-Yvelines.ORCID 0000-0002-9302-4858
A A Kingb Department of Ecology and Evolutionary Biology , University of Michigan , Ann Arbor , MI , USA.ORCID 0000-0001-6159-3207
P Rohanie Odum School of Ecology , University of Georgia , Athens , GA , USA.ORCID 0000-0002-7221-3801

Funding

Understanding Transmission with Integrated Genetic and Epidemiologic InferenceU54GM111274 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BEDFORD, TREVOR BC · 2014 to 2018
$12.5M
Integrating immunology, epidemiology, and evolution to understand and control perR01AI101155 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KING, AARON A., ROHANI, PEJMAN · 2012 to 2016
$1.7M
NIAID NIH HHS R01 AI101155NIGMS NIH HHS U54 GM111274
6 · The paper itself

Abstract

The epidemiology of pertussis-a vaccine-preventable respiratory infection typically caused by the bacterium Bordetella pertussis-remains puzzling. Indeed, the disease seems nowhere close to eradication and has even re-emerged in certain countries-such as the US-that have maintained high vaccination coverage. Because the dynamics of pertussis are shaped by past vaccination and natural infection rates, with the relevant timescale spanning decades, the interpretation of such unexpected trends is not straightforward. In this commentary, we propose that mathematical transmission models play an essential role in helping to interpret the data and in closing knowledge gaps in pertussis epidemiology. We submit that recent advances in statistical inference methods now allow us to estimate key parameters, such as the nature and duration of vaccinal immunity, which have to date been difficult to quantify. We illustrate these points with the results of a recent study based on data from Massachusetts (Domenech de Cellès, Magpantay, King, and Rohani, Sci. Transl. Med. 2018;10: eaaj1748. doi:10.1126/scitranslmed.aaj1748), in which we used such methods to elucidate the mechanisms underlying the ongoing resurgence of pertussis. In addition, we list a number of safety checks that can be used to critically assess mathematical models. Finally, we discuss the remaining uncertainties surrounding pertussis vaccines, in particular the acellular vaccines used for teenage booster immunizations.

Indexed as

Models, TheoreticalVaccination CoverageHumansImmunization, SecondaryIncidenceMassachusettsPertussis VaccineWhooping CoughPertussis Vaccinemathematical modelingPertussis epidemiologypertussis resurgencepertussis vaccinesstatistical inference

Identifiers

PMID30457424
PMCPMC6988877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.